Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease

被引：0

作者：

Malo de Molina, Rosa ^{[1
]}

Restrepo, Marcos I. ^{[2
,3
]}

Mortensen, Eric M. ^{[2
,4
]}

Izquierdo, Jose L. ^{[5
]}

Anzueto, Antonio ^{[2
,3
]}

机构：

[1] Hosp Univ Puerta Hierro Majadahonda, Dept Pulm Med, Madrid, Spain

[2] South Texas Vet Hlth Care Syst, VERDICT Res Unit, San Antonio, TX USA

[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Dept Pulm & Crit Care Med, San Antonio, TX USA

[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Gen Internal Med, San Antonio, TX USA

[5] Hosp Univ Guadalajara, Dept Pulm Med, Guadalajara, Spain

来源：

CURRENT RESPIRATORY MEDICINE REVIEWS | 2010年 / 6卷 / 03期

关键词：

Chronic obstructive pulmonary disease; pneumonia; inhaled corticosteroids;

D O I：

10.2174/157339810791526229

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Inhaled corticosteroids (ICS) have been recommended for use in patients with chronic obstructive pulmonary disease (COPD) in order to decrease exacerbation rates and improve health related quality of life parameters. Nevertheless, recent studies have reported an increased risk of pneumonia associated with this treatment. However, most studies were not specifically designed to detect pneumonia as a possible secondary effect and for this reason it is difficult to determine whether this risk exists and assess its magnitude. This paper reviews the published studies reporting pneumonia events in COPD patients treated with ICS.

引用

页码：162 / 166

页数：5

共 50 条

[1] Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease
Finney, Lydia
Berry, Matthew
Singanayagam, Aran
Elkin, Sarah L.
Johnston, Sebastian L.
Mallia, Patrick
[J]. LANCET RESPIRATORY MEDICINE, 2014, 2 (11): : 919 - 932
[2] Inhaled corticosteroids and chronic obstructive pulmonary disease
Sapey, E
Langford, NJ
Kendall, MJ
[J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2000, 25 (04) : 235 - 238
[3] Inhaled corticosteroids for chronic obstructive pulmonary disease
Park, Hye Yun
Man, S. F. Paul
Sin, Don D.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
[4] Risk of pneumonia with inhaled corticosteroids for stable chronic obstructive pulmonary disease patients
Ruiz Garcia, Vicente
Compte Torrero, Luis
[J]. MEDICINA CLINICA, 2011, 137 (07): : 302 - 304
[5] Inhaled corticosteroids for chronic obstructive pulmonary disease
Cazzola, Mario
Rogliani, Paola
Novelli, Lucia
Matera, Maria Gabriella
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2489 - 2499
[6] Inhaled corticosteroids in chronic obstructive pulmonary disease: How significant is the risk of pneumonia and should it impact use of inhaled corticosteroids?
Cavallazzi R.
Singh S.
[J]. Current Infectious Disease Reports, 2011, 13 (3) : 296 - 301
[7] Eosinophils and Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Baloira Villar, Adolfo
Pallares Sanmartin, Abel
Nunez Fernandez, Marta
[J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2016, 52 (10): : 541 - 541
[8] Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
Janson, Christer
[J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (04) : 1561 - 1569
[9] Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, Ian A.
Clarke, Melissa S.
Sim, Esther H. A.
Fong, Kwun M.
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (07):
[10] Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease
Barnes, PJ
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (02) : 342 - 344

← 1 2 3 4 5 →